These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6340448)

  • 1. Combined vasodilator therapy for chronic congestive heart failure.
    Cody RJ; Franklin KW; Laragh JH
    Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M
    Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
    Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure.
    Hermanovich J; Awan NA; Lui H; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1211-4. PubMed ID: 6753551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M
    J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
    Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Woo M
    Am J Cardiol; 1990 May; 65(18):1209-12. PubMed ID: 2186605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term control of congestive heart failure with captopril.
    Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
    Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
    Awan NA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
    Massie BM; Packer M; Hanlon JT; Combs DT
    J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
    Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.